Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 237

1.

Enhanced bacterial mutualism through an evolved biofilm phenotype.

Røder HL, Herschend J, Russel J, Andersen MF, Madsen JS, Sørensen SJ, Burmølle M.

ISME J. 2018 Jul 5. doi: 10.1038/s41396-018-0165-2. [Epub ahead of print]

PMID:
29977009
2.

Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy.

Grossi F, Genova C, Rijavec E, Barletta G, Biello F, Dal Bello MG, Meyer K, Roder J, Roder H, Grigorieva J.

Lung Cancer. 2018 Mar;117:64-69. doi: 10.1016/j.lungcan.2017.12.007. Epub 2017 Dec 13.

3.

A Serum Protein Signature Associated with Outcome after Anti-PD-1 Therapy in Metastatic Melanoma.

Weber JS, Sznol M, Sullivan RJ, Blackmon S, Boland G, Kluger HM, Halaban R, Bacchiocchi A, Ascierto PA, Capone M, Oliveira C, Meyer K, Grigorieva J, Asmellash SG, Roder J, Roder H.

Cancer Immunol Res. 2018 Jan;6(1):79-86. doi: 10.1158/2326-6066.CIR-17-0412. Epub 2017 Dec 5.

PMID:
29208646
4.

Antagonism correlates with metabolic similarity in diverse bacteria.

Russel J, Røder HL, Madsen JS, Burmølle M, Sørensen SJ.

Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10684-10688. doi: 10.1073/pnas.1706016114. Epub 2017 Sep 18.

5.

Low-abundant species facilitates specific spatial organization that promotes multispecies biofilm formation.

Liu W, Russel J, Røder HL, Madsen JS, Burmølle M, Sørensen SJ.

Environ Microbiol. 2017 Jul;19(7):2893-2905. doi: 10.1111/1462-2920.13816. Epub 2017 Jul 3.

PMID:
28618083
6.

Structural and nucleic acid binding properties of hepatitis delta virus small antigen.

Alves C, Cheng H, Tavanez JP, Casaca A, Gudima S, Roder H, Cunha C.

World J Virol. 2017 May 12;6(2):26-35. doi: 10.5501/wjv.v6.i2.26.

7.

Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy.

Grossi F, Rijavec E, Genova C, Barletta G, Biello F, Maggioni C, Burrafato G, Sini C, Dal Bello MG, Meyer K, Roder J, Roder H, Grigorieva J.

Br J Cancer. 2017 Jan 3;116(1):36-43. doi: 10.1038/bjc.2016.387. Epub 2016 Nov 29.

8.

Interspecific Bacterial Interactions are Reflected in Multispecies Biofilm Spatial Organization.

Liu W, Røder HL, Madsen JS, Bjarnsholt T, Sørensen SJ, Burmølle M.

Front Microbiol. 2016 Aug 31;7:1366. doi: 10.3389/fmicb.2016.01366. eCollection 2016. Review.

9.

[Psychosocial Situation and Patient Satisfaction among Clients of Cancer Counselling Centers in Saxony].

Götze H, Röder H, Frenschkowski S, Mehnert A.

Psychother Psychosom Med Psychol. 2016 Jul;66(7):266-74. doi: 10.1055/s-0042-105019. Epub 2016 Jul 7. German.

PMID:
27388868
10.

H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization.

Rawat SJ, Araiza-Olivera D, Arias-Romero LE, Villamar-Cruz O, Prudnikova TY, Roder H, Chernoff J.

Curr Biol. 2016 Jun 20;26(12):1556-1563. doi: 10.1016/j.cub.2016.04.027. Epub 2016 May 26.

11.

Genome Sequence of Psychrobacter cibarius Strain W1.

Raghupathi PK, Herschend J, Røder HL, Sørensen SJ, Burmølle M.

Genome Announc. 2016 May 26;4(3). pii: e00078-16. doi: 10.1128/genomeA.00078-16.

12.

Better Utilization of Mouse Models of Neurodegenerative Diseases in Preclinical Studies: From the Bench to the Clinic.

Janus C, Hernandez C, deLelys V, Roder H, Welzl H.

Methods Mol Biol. 2016;1438:311-47. doi: 10.1007/978-1-4939-3661-8_18.

PMID:
27150098
13.

Coexistence facilitates interspecific biofilm formation in complex microbial communities.

Madsen JS, Røder HL, Russel J, Sørensen H, Burmølle M, Sørensen SJ.

Environ Microbiol. 2016 Sep;18(8):2565-74. doi: 10.1111/1462-2920.13335. Epub 2016 Jun 27.

PMID:
27119650
14.

Draft Genome Assembly of Two Pseudoclavibacter helvolus Strains, G8 and W3, Isolated from Slaughterhouse Environments.

Raghupathi PK, Herschend J, Røder HL, Sørensen SJ, Burmølle M.

Genome Announc. 2016 Mar 31;4(2). pii: e00077-16. doi: 10.1128/genomeA.00077-16.

15.

Genome Sequence of Kocuria varians G6 Isolated from a Slaughterhouse in Denmark.

Raghupathi PK, Herschend J, Røder HL, Sørensen SJ, Burmølle M.

Genome Announc. 2016 Mar 31;4(2). pii: e00076-16. doi: 10.1128/genomeA.00076-16.

16.

Draft Genome Sequences of Two Kocuria Isolates, K. salsicia G1 and K. rhizophila G2, Isolated from a Slaughterhouse in Denmark.

Herschend J, Raghupathi PK, Røder HL, Sørensen SJ, Burmølle M.

Genome Announc. 2016 Mar 31;4(2). pii: e00075-16. doi: 10.1128/genomeA.00075-16.

17.

Genome Sequence of Kocuria palustris Strain W4.

Herschend J, Raghupathi PK, Røder HL, Sørensen SJ, Burmølle M.

Genome Announc. 2016 Mar 31;4(2). pii: e00074-16. doi: 10.1128/genomeA.00074-16.

18.

Genome Sequence of Arthrobacter antarcticus Strain W2, Isolated from a Slaughterhouse.

Herschend J, Raghupathi PK, Røder HL, Sørensen SJ, Burmølle M.

Genome Announc. 2016 Mar 31;4(2). pii: e00073-16. doi: 10.1128/genomeA.00073-16.

19.

Studying Bacterial Multispecies Biofilms: Where to Start?

Røder HL, Sørensen SJ, Burmølle M.

Trends Microbiol. 2016 Jun;24(6):503-513. doi: 10.1016/j.tim.2016.02.019. Epub 2016 Mar 19. Review.

PMID:
27004827
20.

Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.

Lehmann A, Wixted JH, Shapovalov MV, Roder H, Dunbrack RL Jr, Robinson MK.

MAbs. 2015;7(6):1058-71. doi: 10.1080/19420862.2015.1088618. Epub 2015 Sep 4.

21.

A Native-like Intermediate Serves as a Branching Point between the Folding and Aggregation Pathways of the Mouse Prion Protein.

Honda RP, Xu M, Yamaguchi KI, Roder H, Kuwata K.

Structure. 2015 Sep 1;23(9):1735-1742. doi: 10.1016/j.str.2015.07.001. Epub 2015 Aug 6.

22.

Interspecies interactions result in enhanced biofilm formation by co-cultures of bacteria isolated from a food processing environment.

Røder HL, Raghupathi PK, Herschend J, Brejnrod A, Knøchel S, Sørensen SJ, Burmølle M.

Food Microbiol. 2015 Oct;51:18-24. doi: 10.1016/j.fm.2015.04.008. Epub 2015 Apr 30.

PMID:
26187823
23.

The Tyrosine Kinase c-Src Specifically Binds to the Active Integrin αIIbβ3 to Initiate Outside-in Signaling in Platelets.

Wu Y, Span LM, Nygren P, Zhu H, Moore DT, Cheng H, Roder H, DeGrado WF, Bennett JS.

J Biol Chem. 2015 Jun 19;290(25):15825-34. doi: 10.1074/jbc.M115.648428. Epub 2015 May 6.

24.

Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.

Gregorc V, Novello S, Lazzari C, Barni S, Aieta M, Mencoboni M, Grossi F, De Pas T, de Marinis F, Bearz A, Floriani I, Torri V, Bulotta A, Cattaneo A, Grigorieva J, Tsypin M, Roder J, Doglioni C, Levra MG, Petrelli F, Foti S, Viganò M, Bachi A, Roder H.

Lancet Oncol. 2014 Jun;15(7):713-21. doi: 10.1016/S1470-2045(14)70162-7. Epub 2014 May 13.

25.

Arginyltransferase ATE1 catalyzes midchain arginylation of proteins at side chain carboxylates in vivo.

Wang J, Han X, Wong CC, Cheng H, Aslanian A, Xu T, Leavis P, Roder H, Hedstrom L, Yates JR 3rd, Kashina A.

Chem Biol. 2014 Mar 20;21(3):331-7. doi: 10.1016/j.chembiol.2013.12.017. Epub 2014 Feb 13.

26.

Ultrafast hydrogen exchange reveals specific structural events during the initial stages of folding of cytochrome c.

Fazelinia H, Xu M, Cheng H, Roder H.

J Am Chem Soc. 2014 Jan 15;136(2):733-40. doi: 10.1021/ja410437d. Epub 2013 Dec 31.

27.

Slow folding-unfolding kinetics of an octameric β-peptide bundle.

Montalvo GL, Gai F, Roder H, DeGrado WF.

ACS Chem Biol. 2014 Jan 17;9(1):276-81. doi: 10.1021/cb400621y. Epub 2013 Nov 20.

28.

Nonuniform chain collapse during early stages of staphylococcal nuclease folding detected by fluorescence resonance energy transfer and ultrarapid mixing methods.

Mizukami T, Xu M, Cheng H, Roder H, Maki K.

Protein Sci. 2013 Oct;22(10):1336-48. doi: 10.1002/pro.2320. Epub 2013 Aug 19.

29.

The impact of the conjugative IncP-1 plasmid pKJK5 on multispecies biofilm formation is dependent on the plasmid host.

Røder HL, Hansen LH, Sørensen SJ, Burmølle M.

FEMS Microbiol Lett. 2013 Jul;344(2):186-92. doi: 10.1111/1574-6968.12175. Epub 2013 Jun 3.

30.

A single mutation in a regulatory protein produces evolvable allosterically regulated catalyst of nonnatural reaction.

Moroz OV, Moroz YS, Wu Y, Olsen AB, Cheng H, Mack KL, McLaughlin JM, Raymond EA, Zhezherya K, Roder H, Korendovych IV.

Angew Chem Int Ed Engl. 2013 Jun 10;52(24):6246-9. doi: 10.1002/anie.201302339. Epub 2013 Apr 29. No abstract available.

31.

VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528.

Gautschi O, Dingemans AM, Crowe S, Peters S, Roder H, Grigorieva J, Roder J, Zappa F, Pless M, Brutsche M, Baty F, Bubendorf L, Hsu Schmitz SF, Na KJ, Carbone D, Stahel R, Smit E.

Lung Cancer. 2013 Jan;79(1):59-64. doi: 10.1016/j.lungcan.2012.10.006. Epub 2012 Nov 1.

PMID:
23122759
32.

VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.

Kuiper JL, Lind JS, Groen HJ, Roder J, Grigorieva J, Roder H, Dingemans AM, Smit EF.

Br J Cancer. 2012 Nov 20;107(11):1820-5. doi: 10.1038/bjc.2012.470. Epub 2012 Oct 18.

33.

Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity.

Yao C, Johnson WM, Gao Y, Wang W, Zhang J, Deak M, Alessi DR, Zhu X, Mieyal JJ, Roder H, Wilson-Delfosse AL, Chen SG.

Hum Mol Genet. 2013 Jan 15;22(2):328-44. doi: 10.1093/hmg/dds431. Epub 2012 Oct 12.

34.

Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trial.

Carbone DP, Ding K, Roder H, Grigorieva J, Roder J, Tsao MS, Seymour L, Shepherd FA.

J Thorac Oncol. 2012 Nov;7(11):1653-60. doi: 10.1097/JTO.0b013e31826c1155.

35.

Microsecond folding dynamics of apomyoglobin at acidic pH.

Xu M, Beresneva O, Rosario R, Roder H.

J Phys Chem B. 2012 Jun 14;116(23):7014-25. doi: 10.1021/jp3012365. Epub 2012 Apr 17.

36.

Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors.

Lazzari C, Spreafico A, Bachi A, Roder H, Floriani I, Garavaglia D, Cattaneo A, Grigorieva J, Viganò MG, Sorlini C, Ghio D, Tsypin M, Bulotta A, Bergamaschi L, Gregorc V.

J Thorac Oncol. 2012 Jan;7(1):40-8. doi: 10.1097/JTO.0b013e3182307f17.

37.

Microsecond unfolding kinetics of sheep prion protein reveals an intermediate that correlates with susceptibility to classical scrapie.

Chen KC, Xu M, Wedemeyer WJ, Roder H.

Biophys J. 2011 Sep 7;101(5):1221-30. doi: 10.1016/j.bpj.2011.07.024.

38.

Retroviral integrases promote fraying of viral DNA ends.

Katz RA, Merkel G, Andrake MD, Roder H, Skalka AM.

J Biol Chem. 2011 Jul 22;286(29):25710-8. doi: 10.1074/jbc.M111.229179. Epub 2011 May 27.

39.

Design of a switchable eliminase.

Korendovych IV, Kulp DW, Wu Y, Cheng H, Roder H, DeGrado WF.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6823-7. doi: 10.1073/pnas.1018191108. Epub 2011 Apr 11.

40.

Intact recovery from early 'acquired methylmalonic aciduria' secondary to maternal atrophic gastritis.

Weber-Ferro W, Hertzberg C, Röder H, Timme K, Rossi R.

Acta Paediatr. 2011 Sep;100(9):e138-40. doi: 10.1111/j.1651-2227.2011.02242.x. Epub 2011 Mar 24.

PMID:
21352365
41.

In situ mass spectrometry of autoimmune liver diseases.

Bowlus CL, Seeley EH, Roder J, Grigorieva J, Roder H, Caprioli RM, Gershwin M.

Cell Mol Immunol. 2011 May;8(3):237-42. doi: 10.1038/cmi.2010.72. Epub 2011 Jan 24.

42.
43.

Intrinsic disorder and oligomerization of the hepatitis delta virus antigen.

Alves C, Cheng H, Roder H, Taylor J.

Virology. 2010 Nov 25;407(2):333-40. doi: 10.1016/j.virol.2010.08.019. Epub 2010 Sep 19.

44.

Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.

Chung CH, Seeley EH, Roder H, Grigorieva J, Tsypin M, Roder J, Burtness BA, Argiris A, Forastiere AA, Gilbert J, Murphy B, Caprioli RM, Carbone DP, Cohen EE.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):358-65. doi: 10.1158/1055-9965.EPI-09-0937. Epub 2010 Jan 19.

45.

VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab.

Carbone DP, Salmon JS, Billheimer D, Chen H, Sandler A, Roder H, Roder J, Tsypin M, Herbst RS, Tsao AS, Tran HT, Dang TP.

Lung Cancer. 2010 Sep;69(3):337-40. doi: 10.1016/j.lungcan.2009.11.019. Epub 2009 Dec 29.

46.

Genetic and proteomic features associated with survival after treatment with erlotinib in first-line therapy of non-small cell lung cancer in Eastern Cooperative Oncology Group 3503.

Amann JM, Lee JW, Roder H, Brahmer J, Gonzalez A, Schiller JH, Carbone DP.

J Thorac Oncol. 2010 Feb;5(2):169-78. doi: 10.1097/JTO.0b013e3181c8cbd9.

47.

Autoinhibitory interactions between the PDZ2 and C-terminal domains in the scaffolding protein NHERF1.

Cheng H, Li J, Fazlieva R, Dai Z, Bu Z, Roder H.

Structure. 2009 May 13;17(5):660-9. doi: 10.1016/j.str.2009.03.009.

48.

Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.

Yue M, Hanna A, Wilson J, Roder H, Janus C.

Neurobiol Aging. 2011 Apr;32(4):590-603. doi: 10.1016/j.neurobiolaging.2009.04.006. Epub 2009 May 7.

PMID:
19427061
49.

Competition between reversible aggregation and loop formation in denatured iso-1-cytochrome c.

Tzul FO, Kurchan E, Roder H, Bowler BE.

Biochemistry. 2009 Jan 20;48(2):481-91. doi: 10.1021/bi801977j.

50.

Quantitative matrix-assisted laser desorption/ionization mass spectrometry.

Duncan MW, Roder H, Hunsucker SW.

Brief Funct Genomic Proteomic. 2008 Sep;7(5):355-70. doi: 10.1093/bfgp/eln041. Review.

Supplemental Content

Support Center